Ankur Dhingra, Chief Financial Officer at Summit Therapeutics Inc. (SMMT), bought 392,724 shares at $1.05 ($412K) on 2023-03-07, disclosed to the SEC on 2023-03-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.05 | 196,362 | $206K | 50.0% |
| 2 | $1.05 | 196,362 | $206K | 50.0% |
| Total | $1.05 avg | 392,724 | $412K | 100% |
| Filing → |
| SMMT | BUY | 2023-12-13 | $44K | — | Filing → |
| SMMT | BUY | 2023-03-08 | $13K | — | Filing → |
| SMMT | BUY | 2022-08-17 | $35K | — | Filing → |